Press release
Nanomedicine Market to Reach USD 368.05 Billion by 2030, Growing at a CAGR of 12.1%
Nanomedicine Market
The global nanomedicine market is experiencing significant growth, driven by advancements in nanotechnology and increasing demand for innovative medical treatments. The market was valued at USD 165.45 billion in 2023 and is projected to grow at a CAGR of 12.1% during the forecast period from 2024 to 2030, reaching USD 368.05 billion by 2030.
This press release provides an in-depth analysis of the nanomedicine market across key regions, focusing on growth opportunities, trends, consolidation activities, and updates in Vietnam, Thailand, Japan, China, South Korea, Singapore, the US, and Europe. Recent mergers, acquisitions, and key developments by leading companies such as Johnson & Johnson, Pfizer, and Merck are also highlighted.
๐๐จ ๐ฅ๐๐๐ซ๐ง ๐ฆ๐จ๐ซ๐, ๐ฌ๐ข๐ฆ๐ฉ๐ฅ๐ฒ ๐๐ฅ๐ข๐๐ค ๐จ๐ง ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค :https://www.maximizemarketresearch.com/request-sample/39223/
Country-Specific Analysis
๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ ๐ข๐ง ๐๐ข๐๐ญ๐ง๐๐ฆ
The nanomedicine market in Vietnam is gaining momentum, with the government supporting healthcare advancements through increased funding. Collaborations between local hospitals and global companies, such as ๐ ๐๐ ๐๐จ๐ซ๐ฉ๐จ๐ซ๐๐ญ๐ข๐จ๐ง, are fostering innovation. Vietnam's rapidly aging population and the rising prevalence of chronic diseases are fueling demand for nanomedicine.
๐๐๐ง๐จ๐ฆ๐๐๐ข๐๐ข๐ง๐ ๐๐ซ๐๐ง๐๐ฌ ๐ข๐ง ๐๐ก๐๐ข๐ฅ๐๐ง๐
Thailand is witnessing growing adoption of nanotechnology in oncology treatments. Major hospitals in Bangkok are partnering with global players like ๐๐ฌ๐ญ๐ซ๐๐๐๐ง๐๐๐ to incorporate nanomedicine therapies. A focus on medical tourism is also propelling the demand for innovative treatments in the country.
๐๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง ๐ข๐ง ๐๐๐ฉ๐๐ง
Japan remains a leader in nanomedicine, with major pharmaceutical companies such as ๐๐๐ค๐๐๐ ๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐จ๐ฆ๐ฉ๐๐ง๐ฒ driving research and development. Recent mergers between ๐๐ญ๐ฌ๐ฎ๐ค๐ ๐๐จ๐ฅ๐๐ข๐ง๐ ๐ฌ and smaller biotech firms are boosting the production of nanomedicine formulations for cardiovascular and neurological disorders.
๐๐จ ๐ฅ๐๐๐ซ๐ง ๐ฆ๐จ๐ซ๐, ๐ฌ๐ข๐ฆ๐ฉ๐ฅ๐ฒ ๐๐ฅ๐ข๐๐ค ๐จ๐ง ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค :https://www.maximizemarketresearch.com/request-sample/39223/
๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ ๐ข๐ง ๐๐ก๐ข๐ง๐
China's nanomedicine market is experiencing exponential growth, supported by government policies promoting local innovation. Companies like ๐๐ข๐ง๐จ๐ฏ๐๐ ๐๐ข๐จ๐ญ๐๐๐ก are investing heavily in nanotechnology for vaccine development. Additionally, collaborations with international firms are enabling faster advancements in cancer treatment solutions.
๐๐ซ๐๐ง๐๐ฌ ๐ข๐ง ๐๐จ๐ฎ๐ญ๐ก ๐๐จ๐ซ๐๐
South Korea is a hub for nanotechnology research, with institutions like the ๐๐จ๐ซ๐๐ ๐๐ง๐ฌ๐ญ๐ข๐ญ๐ฎ๐ญ๐ ๐จ๐ ๐๐๐ข๐๐ง๐๐ ๐๐ง๐ ๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ (๐๐๐๐) playing a vital role. Recent developments in targeted drug delivery systems are expected to drive market growth. The country also focuses on enhancing exports of nanomedicine solutions to neighboring regions.
๐๐๐ง๐จ๐ฆ๐๐๐ข๐๐ข๐ง๐ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐๐ข๐ง๐ ๐๐ฉ๐จ๐ซ๐
Singapore's well-established healthcare system and strategic government initiatives have positioned it as a key player in the nanomedicine market. Partnerships between local research institutions and global companies, such as ๐๐ฅ๐๐ฑ๐จ๐๐ฆ๐ข๐ญ๐ก๐๐ฅ๐ข๐ง๐ (๐๐๐), are accelerating the adoption of nanotechnology-based treatments.
๐๐จ ๐ฅ๐๐๐ซ๐ง ๐ฆ๐จ๐ซ๐, ๐ฌ๐ข๐ฆ๐ฉ๐ฅ๐ฒ ๐๐ฅ๐ข๐๐ค ๐จ๐ง ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค :https://www.maximizemarketresearch.com/request-sample/39223/
๐๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง ๐ข๐ง ๐ญ๐ก๐ ๐๐
The US leads the global nanomedicine market, accounting for the largest share in 2023. Mergers between key players like ๐๐ฆ๐ ๐๐ง and emerging biotech firms are fueling innovation. The market is driven by increasing R&D investments and growing applications in oncology, cardiology, and infectious diseases.
๐๐ฉ๐๐๐ญ๐ข๐จ๐ง ๐ข๐ง ๐๐ฎ๐ซ๐จ๐ฉ๐
Europe's nanomedicine market continues to expand, driven by the EU's Horizon 2020 program. Companies such as ๐๐จ๐๐ก๐ and ๐๐จ๐ฏ๐๐ซ๐ญ๐ข๐ฌ are focusing on developing advanced therapeutic solutions. Germany, France, and the UK are leading the region in clinical trials and commercialization of nanomedicine products.
๐๐๐ฒ ๐๐๐๐๐ง๐ญ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ
Johnson & Johnson acquired a biotech startup specializing in nanotechnology-based drug delivery systems.
Pfizer launched a new nanomedicine platform targeting neurodegenerative diseases.
The EU approved funding for several nanomedicine projects under its Horizon 2020 program.
Merck partnered with a South Korean research institute to develop innovative cancer therapies.
๐ ๐จ๐ซ ๐ ๐๐๐ญ๐๐ข๐ฅ๐๐ ๐จ๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ, ๐๐ฅ๐ข๐๐ค ๐จ๐ง ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐๐:https://www.maximizemarketresearch.com/market-report/nanomedicine-market/39223/
๐๐๐ง๐จ๐ฆ๐๐๐ข๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง
๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐๐ญ ๐๐ฒ๐ฉ๐
Diagnostics and Imaging
Treatment
๐๐ฒ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง
Drug Delivery
Diagnostic and Imaging
Vaccines
Regenerative Medicine
Implants
Others
๐๐ฒ ๐๐ง๐๐ข๐๐๐ญ๐ข๐จ๐ง
Clinical Oncology
Infectious Diseases
Clinical Cardiology
Orthopedics
Neurology
Urology
Ophthalmology Immunology
Others
๐๐๐ง๐จ๐ฆ๐๐๐ข๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ
๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ง๐จ๐ฆ๐๐๐ข๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฃ๐จ๐ซ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
1. Elan Corporation (Ireland)
2. Taiwan Liposome Company Ltd (Taiwan)
3. NanoCarrier Co. Ltd (Japan)
4. LiPlasome Pharma ApS (Denmark)
5. Starpharma Holdings Limited (Australia)
6. Sanofi SA (France)
7. Bristol-Myers Squibb Company (U.S.)
8. Teva Pharmaceutical Industries Ltd. (Israel)
9. Spago Nanomedical AB (Sweden)
๐๐๐๐๐ข๐ง๐ ๐๐๐ง๐จ๐ฆ๐๐๐ข๐๐ข๐ง๐๐ฌ ๐๐ซ๐จ๐ฏ๐ข๐๐๐ซ๐ฌ ๐ข๐ง ๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐:
1. BIND Therapeutics (U.S.)
2. Ensysce Biosciences (U.S.)
3. Genzyme Corporation (U.S.)
4. Gilead Sciences (U.S.)
5. Insys Therapeutics (U.S.)
6. Intarcia Therapeutics (U.S.)
7. Nanoprobes (U.S.)
8. Nanosphere Health Sciences (U.S.)
9. Abbott Laboratories (U.S.)
10. CombiMatrix Corporation (U.S.)
11. Celgene Corporation (U.S.)
12. GE Healthcare (U.S.)
13. Johnson & Johnson Services, Inc. (U.S.)
14. Mallinckrodt Pharmaceuticals (U.S.)
15. Merck & Co., Inc. (U.S.)
16. Pfizer, Inc. (U.S.)
17. Arrowhead Pharmaceuticals, Inc. (U.S.)
18. CytImmune Sciences Inc. (U.S.)
19. Luminex Corporation (U.S.)
20. Copernicus Therapeutics Inc. (U.S.)
21. Ocuphire Pharma Inc. (U.S.)
22. Name Therapeutics Corp. (U.S.)
23. Genetic Immunity (U.S.)
๐๐๐ฃ๐จ๐ซ ๐๐๐ง๐จ๐ฆ๐๐๐ข๐๐ข๐ง๐ ๐๐ซ๐จ๐ฏ๐ข๐๐๐ซ๐ฌ ๐ข๐ง ๐๐ฎ๐ซ๐จ๐ฉ๐:
1. Ablynx (Belgium)
2. Nanobiotix (France)
3. Nanospectra Biosciences (France)
4. Stealth BioTherapeutics (U.S. & Europe - headquarters in Ireland)
๐๐ข๐ฌ๐๐จ๐ฏ๐๐ซ ๐๐ก๐๐ญ'๐ฌ ๐๐ซ๐๐ง๐๐ข๐ง๐ :
โฆ Surgical Microscopes Market https://www.maximizemarketresearch.com/market-report/surgical-microscopes-market/124768/
โฆ Global Medical Coding Market https://www.maximizemarketresearch.com/market-report/global-medical-coding-market/91813/
โฆ Dental Equipment Market https://www.maximizemarketresearch.com/market-report/dental-equipment-market/309/
โฆ Global Weight Loss Services Market https://www.maximizemarketresearch.com/market-report/global-weight-loss-services-market/97003/
โฆ Middle East Emergency Medical Service Ems Products Market https://www.maximizemarketresearch.com/market-report/middle-east-emergency-medical-service-ems-products-market/2882/
โฆ Global Rheumatology Therapeutics Market https://www.maximizemarketresearch.com/market-report/global-rheumatology-therapeutics-market/39217/
โฆ Global Plasma Fractionation Market https://www.maximizemarketresearch.com/market-report/global-plasma-fractionation-market/6677/
โฆ Intraoperative Neurophysiological Monitoring Market https://www.maximizemarketresearch.com/market-report/intraoperative-neurophysiological-monitoring-market/190253/
โฆ Weight Loss Supplements Market https://www.maximizemarketresearch.com/market-report/weight-loss-supplements-market/219979/
โฆ Sarcoidosis Market https://www.maximizemarketresearch.com/market-report/sarcoidosis-market/188462/
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐๐ฑ๐ข๐ฆ๐ข๐ณ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656
๐๐๐จ๐ฎ๐ญ ๐๐๐ฑ๐ข๐ฆ๐ข๐ณ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nanomedicine Market to Reach USD 368.05 Billion by 2030, Growing at a CAGR of 12.1% here
News-ID: 3827545 • Views: โฆ
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a โฆ
Bangladesh Ceramics Tiles Market size was valued at USD 882.56 Million in 2023 and the total Bangladesh Ceramics Tiles Market revenue is expected to grow at a CAGR of 13.71 % from 2024 to 2030, reaching nearly USD 2169.38 Million.
Bangladesh Ceramics Tiles Market Overview:
The Bangladesh ceramics tiles market is a vital component of the country's construction and building materials industry, driven by rapid urbanization, infrastructure development, and rising disposable incomes.โฆ
Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
Furfural Market size was valued at USD 630.2Mn in 2023. The Furfural Market revenue is growing at a CAGR of 6.8 % from 2023 to 2029, reaching nearly USD 998.30 Bn by 2030.
Furfural Market Overview:
The furfural market is centered around an organic compound derived primarily from agricultural byproducts such as corn cobs, sugarcane bagasse, and rice husks through a process of acid hydrolysis. As one of the oldest renewable chemicals,โฆ
Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to โฆ
Chemical Protective Clothing Market size was valued at USD 1.57 Billion in 2024 and the total Chemical Protective Clothing revenue is expected to grow at a CAGR of 5.59% from 2025 to 2032, reaching nearly USD 2.42 Billion.
Chemical Protective Clothing Market Overview:
The Chemical Protective Clothing (CPC) market comprises garments and accessories specifically designed to shield workers from exposure to hazardous chemicals, liquids, and particulate matter across a wide range ofโฆ
Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR โฆ
Prefabricated Homes Market size was valued at USD 18.58 Billion in 2024 and the total Prefabricated Homes revenue is expected to grow at a CAGR of 6.19% from 2025 to 2032, reaching nearly USD 30.04 Billion.
Prefabricated Homes Market Overview:
The prefabricated homes market, also known as modular or off-site construction, involves the manufacturing of building components in a controlled factory environment before their assembly at the final location. This method revolutionizesโฆ
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | โฆ
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of theโฆ
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme โฆ
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,โฆ
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN โฆ
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growthโฆ
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, โฆ
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin'sโฆ
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep โฆ
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways fromโฆ
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut โฆ
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significantโฆ
